Zynerba Pharma CS (ZYNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 8,904 | 8,836 | 10,211 | 9,839 | 7,885 |
| Operating Income | -8,904 | -8,836 | -10,211 | -9,839 | -7,885 |
| Other Income | 413 | 21 | -372 | -112 | -77 |
| Pre-tax Income | -8,491 | -8,815 | -10,582 | -9,950 | -7,962 |
| Net Income Continuous | -8,491 | -8,815 | -10,582 | -9,950 | -7,962 |
| Net Income | $-8,491 | $-8,815 | $-10,582 | $-9,950 | $-7,962 |
| EPS Basic Total Ops | -0.21 | -0.24 | -0.26 | -0.25 | -0.20 |
| EPS Basic Continuous Ops | -0.21 | -0.24 | -0.26 | -0.25 | -0.20 |
| EPS Diluted Total Ops | -0.21 | -0.24 | -0.26 | -0.25 | -0.20 |
| EPS Diluted Continuous Ops | -0.21 | -0.24 | -0.26 | -0.25 | -0.20 |
| EPS Diluted Before Non-Recurring Items | -0.21 | -0.22 | -0.26 | N/A | N/A |
| EBITDA(a) | $-8,843 | $-8,775 | $-10,149 | $-9,777 | $-7,823 |